Business Context and Reporting Period
This Form 6-K filing by Ellomay Capital Ltd. is dated October 21, 2020. The report details the completion of an early institutional and classified investors tender in Israel. The tender relates to an offering of additional Series C Debentures and a new series of options (Series 1 Options) to purchase ordinary shares at an exercise price of NIS 150 (approximately $44.4) per share.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or total debt. The financial data presented is specific to the capital raising transaction:
- Units Offered: Each unit consists of NIS 2,000 par value Series C Debentures and 5 Series 1 Options.
- Early Commitments Received: Bidders submitted orders for an aggregate of 133,280 units.
- Accepted Commitments: The Company intends to accept early commitments for 71,888 units.
- Price Per Unit: NIS 2,124.
- Early Commitment Commission: 0.35% paid to institutional and classified investors.
Material Changes
The filing does not report material changes to historical financial results or operations compared to prior periods. The primary material event is the execution of the institutional tender, which establishes a minimum price for the upcoming public tender of the new securities.
Guidance, Outlook, and Risks
Outlook and Conditions: The issuance of the securities is subject to listing approvals, Board of Directors approval, and the completion of a public tender. The final structure and date of the public tender will be published in a Shelf Offering Report in Hebrew. The offering is restricted to Israel and is not registered under the U.S. Securities Act of 1933.
Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. Actual results may differ materially due to market conditions and the receipt of required approvals. The Company does not undertake an obligation to update these statements.
Key Facts for Investor Verification
- Verify the final outcome of the public tender following this institutional phase.
- Confirm receipt of necessary listing approvals and Board of Directors approval for the issuance.
- Review the Hebrew Shelf Offering Report for the final structure of the offering.
- Note that the securities are not registered in the U.S. and are not available to U.S. persons.